Biocon Archives - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in the US for $7.7 million.

Biocon buys Eywa Pharma’s US facility for $7.7 million

HQ Team September 6, 2023: Biocon Ltd., an Indian biopharmaceutical company, has acquired Eywa Pharma Inc., an oral solid dosage manufacturing facility in.

by HealthQuill
September 6, 2023
0 Comments

Drugs Pharma

Biocon signs out-licencing pact with Yoshindo

HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling.

by HealthQuill
October 17, 2022
0 Comments

About Us

Contact Info

Follow Us

Biocon buys Eywa Pharma’s US facility for $7.7 million

Biocon signs out-licencing pact with Yoshindo